Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | GILD | VRTX | ||
| Company | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 56.46 | 123.80 | 440.46 | ||
| High | 56.56 | 125.12 | 445.77 | ||
| Low | 55.10 | 122.10 | 437.46 | ||
| Latest | 55.26 | 124.91 | 441.36 | ||
| Change | -1.36 | +3.65 | +2.44 | ||
| % Change | -2.40% | +3.01% | +0.56% | ||
| Volume | 13,702,800 | 10,639,000 | 2,047,400 | ||
| 20-Day Average Volume | 14,318,740 | 6,405,805 | 1,381,860 | ||
| Previous Close | 56.62 | 121.26 | 438.92 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.90 | 122.91 | 457.40 | ||
| 20-Day Raw Stochastic | 64.26% | 76.26% | 9.19% | ||
| 20-Day Relative Strength | 59.07 | 53.81 | 46.77 | ||
| Weighted Alpha | +6.63 | +32.21 | +4.19 | ||
| Today's Opinion | 100% Buy | 72% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 40% Buy | 40% Buy | ||
| Last Month's Opinion | 72% Buy | 56% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.07% since 01/09/26 | +3.15% since 01/09/26 | -4.85% since 01/09/26 | ||
| Low | 55.10 on 01/16/26 | 119.63 on 01/12/26 | 436.69 on 01/15/26 | ||
| High | 57.04 on 01/14/26 | 125.12 on 01/16/26 | 464.59 on 01/12/26 | ||
| 1-Month | |||||
| %Chg | +1.90% since 12/16/25 | +5.16% since 12/16/25 | -2.99% since 12/16/25 | ||
| Low | 52.06 on 01/05/26 | 116.88 on 01/05/26 | 436.69 on 01/15/26 | ||
| High | 57.04 on 01/14/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +27.36% since 10/16/25 | +5.99% since 10/16/25 | +8.01% since 10/16/25 | ||
| Low | 42.52 on 10/29/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 | ||
| High | 57.04 on 01/14/26 | 128.70 on 11/20/25 | 487.52 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +17.15% since 07/16/25 | +13.71% since 07/16/25 | -6.00% since 07/16/25 | ||
| Low | 42.52 on 10/29/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 | ||
| High | 57.04 on 01/14/26 | 128.70 on 11/20/25 | 487.52 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 112,495,712 | 154,973,344 | 111,981,408 | ||
| Shares Outstanding, K | 2,035,753 | 1,240,680 | 253,719 | ||
| Annual Sales | 48,300,000,000 | 28,754,000,000 | 11,020,100,000 | ||
| Annual Net Income | -8,948,000,000 | 480,000,000 | -535,600,000 | ||
| Last Quarter Sales | 12,222,000,000 | 7,769,000,000 | 3,076,400,000 | ||
| Last Quarter Net Income | 2,201,000,000 | 3,052,000,000 | 1,082,900,000 | ||
| 60-Month Beta | 0.29 | 0.33 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.63 on 10/30/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 | ||
| Latest Earnings Date | 02/05/26 | 02/10/26 | 02/09/26 | ||
| Most Recent Dividend | 0.630 on 01/02/26 | 0.790 on 12/15/25 | N/A | ||
| Next Ex-Dividends Date | 01/02/26 | 12/15/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 8.63 | 14.81 | 28.67 | ||